​

Funding Round

Series C - Apollo Therapeutics

Series C - Apollo Therapeutics

Investment Firm

Overview

Apollo Therapeutics is a portfolio biopharmaceutical company focused on translating medical research into medicines.

Announced Date

Jan 02, 2024

Closed on Date

Jan 02, 2024

Funding Type

Series C

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Patient Square Capital

Patient Square Capital

Patient Square Capital is a early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Participant Investors

3

Investor Name
Participant InvestorRock Springs Capital
Participant InvestorM&G Plc
Participant InvestorPatient Square Capital

Round Details and Background

Apollo Therapeutics raised $33500000 on 2024-01-02 in Series C

Apollo Therapeutics is a portfolio biopharmaceutical company focused on translating medical research into medicines.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 01, 2017
Seed Round - Apollo Therapeutics
1-undefined
Jun 17, 2021
Series B - Apollo Therapeutics
4-139.4M
Sep 06, 2023
Series C - Apollo Therapeutics
3-225.0M
Jan 02, 2024
Series C - Apollo Therapeutics
3-33.5M

Recent Activity

There is no recent news or activity for this profile.